Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CHILD PAIN-FEVER 160 MG/5 ML

Acetaminophen
$0.0205per ML
OTC

Strength

160 mg/5mL

Manufacturer

Topco Associates LLC

NDC

36800020226

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

6/23/2021

Active Ingredients

ACETAMINOPHEN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M013

On Market Since

1/15/1990

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

+3.4%

All

+5.7%

Generic Alternatives

Save up to 37%

10 alternatives • Same active ingredient

ACETAMINOPHEN 160 MG/5 ML LIQ
Generic
69367032316•Westminster Pharmaceuticals LLC
$0.0128
Save 37%
ACETAMINOPHEN 160 MG/5 ML LIQ
Generic
54859080916•Llorens Pharmaceutical International Division
$0.0128
Save 37%
CHLD ACETAMINOPHEN 160 MG/5 ML
Generic
00904701416•Major Pharmaceuticals
$0.0128
Save 37%
M-PAP 160 MG/5 ML LIQUID
Generic
58657052416•Method Pharmaceuticals LLC
$0.0128
Save 37%
CHILD PAIN-FEVER 160 MG/5 ML
Generic
83720050016•Oncor Pharmaceuticals
$0.0128
Save 37%
ACETAMINOPHEN 160 MG/5 ML SOLN
Generic
57237030416•Rising Pharma Holdings Inc.
$0.0128
Save 37%
CHLD ACETAMINOPHEN 160 MG/5 ML
Generic
82568000806•Aarna USA Inc.
$0.0128
Save 37%
CHLD ACETAMINOPHEN 160 MG/5 ML
Generic
00536132197•Rugby Laboratories
$0.0208
+1% more
FT CHILD PAIN-FEVER 160 MG/5 ML
Generic
70677114301•Strategic Sourcing Services LLC
$0.0208
+1% more
CHILD PAIN-FEVER 160 MG/5 ML
Generic
46122021026•AmerisourceBergen
$0.0208
+1% more

Related Drugs

Same classification

No related drugs found.

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy